Company news
Advanced Biomed Inc. (NASDAQ:ADVB) news
Advanced Biomed Inc. news releases on 6ix. Latest, Feb 18, 2026: Advanced Biomed Inc. Announces 1 for 20 Share Consolidation
Press releases & updates
Advanced Biomed Inc. Announces 1 for 20 Share Consolidation
February 17, 2026
Advanced Biomed Inc. Announces 120-Case Feasibility Study with Chi-Mei Medical Center to Validate A+PerfusC, Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery
February 16, 2026
Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery
February 13, 2026
Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary
December 30, 2025
Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary
December 29, 2025
Advanced Biomed Inc. Announces Launch of A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery
September 19, 2025
Advanced Biomed Inc. Announces Closing Of US$6.56 Million Initial Public Offering
March 7, 2025
Advanced Biomed Inc. Announces Pricing of Initial Public Offering
March 6, 2025